Pyridazion quinoline compounds
US5744471A · kind A · utility
30Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 1996 |
| Grant date | Apr 28, 1998 |
| Priority date | — |
| Expiry date | Apr 17, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula (I) in the treatment and/or prevention of certain diseases or conditions. In formula (I), A is chosen from ortho substituted aryl or heteroaryl species, X is chosen from --OH, --SH, NHR and R.sup.1 or R.sup.2 is chosen from --(CH.sub.2).sub.n L wherein L may be selected from a variety of substituents including aryl, heteroaryl and heterocyclic groups. The compounds are useful in treating and/or preventing neurological disorders associated with excitatory amino acids. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.